SEC Form 4 · accession 0000200406-26-000175
JOHNSON & JOHNSON · JNJ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jennifer L Taubert
Officer — EVP, WWC. Innovative Medicine
Period of report
Aug 17, 2026
Accepted (ET)
Aug 18, 2026 · 6:31 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000200406
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 17, 2026 | M | 15,000 | $115.67 | A | 209,451 | D | |
| Common StockF1 | Aug 17, 2026 | S | 15,000 | $263.36 | D | 194,451 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Options (Right to Buy)F2 | $115.67 | Aug 17, 2026 | M | 15,000 | D | Feb 13, 2020 | Feb 13, 2027 | Common Stock | 15,000 | 28,712 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $263.30 to $263.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.